Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7822099rdf:typepubmed:Citationlld:pubmed
pubmed-article:7822099lifeskim:mentionsumls-concept:C0027930lld:lifeskim
pubmed-article:7822099lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7822099lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:7822099lifeskim:mentionsumls-concept:C0205549lld:lifeskim
pubmed-article:7822099lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:7822099lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:7822099pubmed:issue3lld:pubmed
pubmed-article:7822099pubmed:dateCreated1995-2-16lld:pubmed
pubmed-article:7822099pubmed:abstractTextNeurotensin (NT), is a linear tetradecapeptide (pGlu1-Leu2-Tyr3-Glu4-Asn5- Lys6-Pro7-Arg8-Arg9-Pro10-Tyr11-Ile12-Leu13) that has been found in the central nervous system and peripheral tissues and appears to have a variety of physiological properties. A C-terminal hexapeptide analogue [N alpha Me-Arg-Lys-Pro-Trp-Tle-Leu, (1) Tle = tert-leucine] has recently been reported to have high affinity for the NT receptor and appears to possess central activity after systemic administration. In an effort to probe the structure-activity and conformational properties of the dipeptide, Pro-Trp for binding and functional activity, these residues have been substituted with several natural and unnatural amino acids. Some of these analogues have binding affinities similar to compound 1, while in other cases, such as D-amino acid substitutions, the peptides had negligible binding affinity. In general, the Pro10 position seems more tolerant of substitution by amino acids that favor a reverse turn, rather than those that favor an extended conformation. The Trp11 position accepted extra steric bulk more readily than conformational constraints.lld:pubmed
pubmed-article:7822099pubmed:languageenglld:pubmed
pubmed-article:7822099pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822099pubmed:citationSubsetIMlld:pubmed
pubmed-article:7822099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822099pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7822099pubmed:statusMEDLINElld:pubmed
pubmed-article:7822099pubmed:monthSeplld:pubmed
pubmed-article:7822099pubmed:issn0367-8377lld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:PugsleyT ATAlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:DavisM DMDlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:SawyerT KTKlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:HeffnerT GTGlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:LOWYA DADlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:AkunneH CHClld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:HeJ XJXlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:WustrowD JDJlld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:CorbinA EAElld:pubmed
pubmed-article:7822099pubmed:authorpubmed-author:SeflerA MAMlld:pubmed
pubmed-article:7822099pubmed:issnTypePrintlld:pubmed
pubmed-article:7822099pubmed:volume44lld:pubmed
pubmed-article:7822099pubmed:ownerNLMlld:pubmed
pubmed-article:7822099pubmed:authorsCompleteNlld:pubmed
pubmed-article:7822099pubmed:pagination233-8lld:pubmed
pubmed-article:7822099pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:meshHeadingpubmed-meshheading:7822099-...lld:pubmed
pubmed-article:7822099pubmed:year1994lld:pubmed
pubmed-article:7822099pubmed:articleTitleStructure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.lld:pubmed
pubmed-article:7822099pubmed:affiliationDepartment of Chemistry, Warner-Lambert Co., Ann Arbor, Michigan.lld:pubmed
pubmed-article:7822099pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7822099pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7822099lld:pubmed